We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ACXP market cap is 11.74M. The company's latest EPS is USD -0.6006 and P/E is -0.85.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.38M | -4.12M | -2.82M | -2.78M | -2.15M |
| Net Income | -4.38M | -4.12M | -2.82M | -2.78M | -2.15M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -12.81M | -12.09M | -14.58M | -14.1M |
| Net Income | -12.75M | -12.09M | -14.58M | -14.1M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 9.11M | 6.58M | 5.98M | 3.86M | 4.81M |
| Total Liabilities | 3.11M | 3.15M | 3.32M | 3.24M | 2.49M |
| Total Equity | 6M | 3.43M | 2.66M | 615k | 2.31M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.25M | 9.38M | 7.71M | 3.86M |
| Total Liabilities | 844k | 2.06M | 3.04M | 3.24M |
| Total Equity | 12.41M | 7.32M | 4.67M | 615k |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -3.06M | -5.94M | -8.13M | -10.38M | -2.05M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.51M | 4.83M | 6.42M | 6.62M | 2.99M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.01M | -7.54M | -9.8M | -10.38M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 14.8M | 3.7M | 8.16M | 6.62M |
| Market Cap | 11.74M |
| Price to Earnings Ratio | -0.85 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.23 |
| Price to Book Ratio | 19.47 |
| Dividend Yield | - |
| Shares Outstanding | 23.48M |
| Average Volume (1 week) | 635.25k |
| Average Volume (1 Month) | 20.34M |
| 52 Week Change | -75.01% |
| 52 Week High | 3.325 |
| 52 Week Low | 0.30 |
| Spread (Intraday) | 0.07 (11.68%) |
| Company Name | Acurx Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.acurxpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
